1. Fishchuk, Liliia, Rossokha, Zoia, Pokhylko, Valeriy, Kovtun, Serhii, Gorovenko, Nataliia. 2022. SFTPB (rs11130866) and NR3C1 (rs41423247) gene variants as potential clinical biomarkers for personalized treatment strategy selection in patients with severe COVID-19 pneumonia. In Respiratory investigation, 61, 103-109. doi:10.1016/j.resinv.2022.10.008. https://pubmed.ncbi.nlm.nih.gov/36460583/
2. Wang, Kun, Huang, Qiubo, Zhao, Guangqiang, Yang, Kaiyun, Huang, Yunchao. 2019. Gene polymorphisms of SFTPB rs7316, rs9752 and PAOX rs1046175 affect the diagnostic value of plasma Pro-SFTPB and DAS in Chinese Han non-small-cell lung cancer patients. In Journal of cellular biochemistry, 120, 14804-14812. doi:10.1002/jcb.28741. https://pubmed.ncbi.nlm.nih.gov/31016788/
3. Jacob, Anjali, Morley, Michael, Hawkins, Finn, Beers, Michael F, Kotton, Darrell N. 2017. Differentiation of Human Pluripotent Stem Cells into Functional Lung Alveolar Epithelial Cells. In Cell stem cell, 21, 472-488.e10. doi:10.1016/j.stem.2017.08.014. https://pubmed.ncbi.nlm.nih.gov/28965766/
4. Cooney, Ashley L, Wambach, Jennifer A, Sinn, Patrick L, McCray, Paul B. 2022. Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction. In Frontiers in genome editing, 3, 785829. doi:10.3389/fgeed.2021.785829. https://pubmed.ncbi.nlm.nih.gov/35098209/
5. Desroziers, Tifenn, Prévot, Grégoire, Coulomb, Aurore, Legendre, Marie, Nathan, Nadia. 2023. Hypomorphic pathogenic variant in SFTPB leads to adult pulmonary fibrosis. In European journal of human genetics : EJHG, 31, 1083-1087. doi:10.1038/s41431-023-01413-w. https://pubmed.ncbi.nlm.nih.gov/37380697/
智鼠故事 
